Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRCP | P42785 | 3/20 | 0.54 |
| ▸ | TLR2 | O60603 | 2/20 | 0.51 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.45 |
| ▸ | NAAA | Q02083 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.39 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL629326 | 1.00 | PRCP (0.54) | PRCPTLR2DPP7NAAAGAA | |
| SCHEMBL7780443 | 0.98 | PRCP (0.56) | PRCPTLR2DPP7NAAAGAA | |
| SCHEMBL7533567 | 0.98 | PRCP (0.56) | PRCPTLR2DPP7NAAAGAA | |
| SCHEMBL9659930 | 0.98 | PRCP (0.56) | PRCPTLR2DPP7NAAAGAA | |
| SCHEMBL9658679 | 0.98 | PRCP (0.56) | PRCPTLR2DPP7NAAAGAA | |
| SCHEMBL9658685 | 0.98 | PRCP (0.56) | PRCPTLR2DPP7NAAAGAA | |
| SCHEMBL7782934 | 0.98 | PRCP (0.56) | PRCPTLR2DPP7NAAAGAA | |
| SCHEMBL7533568 | 0.98 | PRCP (0.56) | PRCPTLR2DPP7NAAAGAA | |
| SCHEMBL7780475 | 0.98 | PRCP (0.56) | PRCPTLR2DPP7NAAAGAA | |
| SCHEMBL9659933 | 0.98 | PRCP (0.56) | PRCPTLR2DPP7NAAAGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 318 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2889306-B1 | ACYL DIPEPTIDE DERIVATIVE | AJINOMOTO KK (JP) | 2018-09-19 | — | — | EP | claimed |
| EP-2832345-B1 | COSMETIC COMPOSITION | AJINOMOTO KK (JP) | 2017-11-22 | — | — | EP | claimed |
| CN-106456633-A | Sugar metabolism improving agent | 三得利控股株式会社 | 2017-02-22 | — | — | CN | claimed |
| CN-106455664-A | Composition with high content of cyclic dipeptide | 三得利控股株式会社 | 2017-02-22 | — | — | CN | claimed |
| US-9464110-B2 | Acyl dipeptide derivative | AJINOMOTO CO., INC. (JP) | 2016-10-11 | — | — | US | claimed |
| US-9211245-B2 | Cosmetic composition | AJINOMOTO CO., INC. (JP) | 2015-12-15 | — | — | US | claimed |
| EP-2889306-A1 | ACYL DIPEPTIDE DERIVATIVE | AJINOMOTO CO., INC. (JP) | 2015-07-01 | — | — | EP | claimed |
| US-20150166600-A1 | ACYL DIPEPTIDE DERIVATIVE | AJINOMOTO CO., INC. (JP) | 2015-06-18 | — | — | US | claimed |
| EP-2832345-A1 | COSMETIC COMPOSITION | Ajinomoto Co., Inc. (JP) | 2015-02-04 | — | — | EP | claimed |
| US-20150010489-A1 | COSMETIC COMPOSITION | AJINOMOTO CO., INC. (JP) | 2015-01-08 | — | — | US | claimed |
| EP-2229157-A1 | COMPRESSED CHEWING GUM TABLET | Fertin Pharma A/S (DK) | 2010-09-22 | — | — | EP | claimed |
| EP-2229156-A1 | CHEWING GUM TABLET AND METHOD OF DOSING PHARMACEUTICALLY ACTIVE INGREDIENTS IN SUCH CHEWING GUM TABLET | Fertin Pharma A/S (DK) | 2010-09-22 | — | — | EP | claimed |
| EP-2229158-A1 | COMPRESSED CHEWING GUM TABLET | Fertin Pharma A/S (DK) | 2010-09-22 | — | — | EP | claimed |
| WO-2009080022-A1 | COMPRESSED CHEWING GUM TABLET | FERTIN PHARMA A/S (DK) | 2009-07-02 | — | — | WO | claimed |
| WO-2009080020-A1 | CHEWING GUM TABLET AND METHOD OF DOSING PHARMACEUTICALLY ACTIVE INGREDIENTS IN SUCH CHEWING GUM TABLET | FERTIN PHARMA A/S (DK) | 2009-07-02 | — | — | WO | claimed |
| WO-2009080021-A1 | COMPRESSED CHEWING GUM TABLET | FERTIN PHARMA A/S (DK) | 2009-07-02 | — | — | WO | claimed |
| US-20240238240-A1 | Cannabinoid Pouch | NORDICCAN A/S (DK) | 2024-07-18 | — | — | US | disclosed |
| WO-2024148322-A1 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF HEARING DISORDERS | GATEWAY BIOTECHNOLOGY, INC. (US) | 2024-07-11 | — | — | WO | disclosed |
| EP-0566135-A1 | Transmucosal composition comprising a peptide and a cytidine derivative | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1993-10-20 | — | — | EP | disclosed |
| WO-1993018060-A1 | NEW ANTICOAGULANT PEPTIDE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AS WELL AS A PROCESS FOR THE PREPARATION THEREOF | Gyógyszerkutató Intézet Kft. (HU) | 1993-09-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150010489-A1 | COSMETIC COMPOSITION | CUTA, TRPA1, MITF | PRCP 3137/4885TLR2 445/4885DPP7 1910/4885 |
| US-20150166600-A1 | ACYL DIPEPTIDE DERIVATIVE | OR10J3, OR51E2, TLR5 | PRCP 4250/4885TLR2 10/4885DPP7 175/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.